<SEC-DOCUMENT>0001193125-17-092858-index.html : 20170323 <SEC-HEADER>0001193125-17-092858.hdr.sgml : 20170323 <ACCEPTANCE-DATETIME>20170323080401 ACCESSION NUMBER: 0001193125-17-092858 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20170502 FILED AS OF DATE: 20170323 DATE AS OF CHANGE: 20170323 EFFECTIVENESS DATE: 20170323 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A8 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 17708195 BUSINESS ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 BUSINESS PHONE: 514-744-6792 MAIL ADDRESS: STREET 1: 2150 ST. ELZEAR BLVD. WEST STREET 2: LAVAL CITY: QUEBEC STATE: A8 ZIP: H7L 4A8 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>d330204ddef14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: d330204ddef14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>g330204g10v55.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: g330204g10v55.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>g330204g28e77.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: g330204g28e77.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g330204g29w56.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g330204g29w56.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>g330204g45x09.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: g330204g45x09.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g330204g69b62.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g330204g69b62.jpg
</DOCUMENT> </SEC-DOCUMENT>